User profiles for STEVEN E. SCHILD
steven schildmayo clinic Verified email at mayo.edu Cited by 38575 |
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship
JR Molina, P Yang, SD Cassivi, SE Schild… - Mayo clinic …, 2008 - Elsevier
Lung cancer is the leading cause of cancer-related mortality not only in the United States
but also around the world. In North America, lung cancer has become more predominant …
but also around the world. In North America, lung cancer has become more predominant …
Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung
Cancer (NSCLC) provide recommended management for patients with NSCLC, including …
Cancer (NSCLC) provide recommended management for patients with NSCLC, including …
Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology
This selection from the NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) focuses
on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic …
on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic …
Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis
…, BA Pockaj, A Bardia, CM Vachon, SE Schild… - Mayo Clinic …, 2007 - Elsevier
Malignant melanoma is an aggressive, therapy-resistant malignancy of melanocytes. The
incidence of melanoma has been steadily increasing worldwide, resulting in an increasing …
incidence of melanoma has been steadily increasing worldwide, resulting in an increasing …
NCCN guidelines insights: non–small cell lung cancer, version 2.2021: featured updates to the NCCN guidelines
… Search for other papers by Steven E. … Before completing these requirements, be sure
your NCCN profile has been updated with your NAPB e-profile ID and date of birth. Your …
your NCCN profile has been updated with your NAPB e-profile ID and date of birth. Your …
[HTML][HTML] Impact of intensity-modulated radiation therapy technique for locally advanced non–small-cell lung cancer: a secondary analysis of the NRG oncology RTOG …
…, RU Komaki, RD Timmerman, SE Schild… - Journal of Clinical …, 2017 - ncbi.nlm.nih.gov
Purpose Although intensity-modulated radiation therapy (IMRT) is increasingly used to treat
locally advanced non–small-cell lung cancer (NSCLC), IMRT and three-dimensional …
locally advanced non–small-cell lung cancer (NSCLC), IMRT and three-dimensional …
NCCN guidelines insights: non–small cell lung cancer, version 1.2020: featured updates to the NCCN guidelines
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of
management for NSCLC. These NCCN Guidelines Insights focus on recent updates in …
management for NSCLC. These NCCN Guidelines Insights focus on recent updates in …
NCCN guidelines® insights: non–small cell lung cancer, version 2.2023: featured updates to the NCCN guidelines
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) provide recommendations
for management of disease in patients with NSCLC. These NCCN Guidelines Insights …
for management of disease in patients with NSCLC. These NCCN Guidelines Insights …
NCCN guidelines insights: non–small cell lung cancer, version 5.2018
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of
management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the …
management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the …
Malignant peripheral nerve sheath tumor: analysis of treatment outcome
WW Wong, T Hirose, BW Scheithauer, SE Schild… - International Journal of …, 1998 - Elsevier
Purpose: To analyze the results of therapy for malignant peripheral nerve sheath tumor (MPNST)
and to identify prognostic factors of survival, and of local and distant control of disease. …
and to identify prognostic factors of survival, and of local and distant control of disease. …